fouremm, well written. Thanks.

I agree entirely but it is what it is. I only hope that when (I hope) the science proves itself that the momentum of the science as an epigenetic breakthrough will be so overwhelming that investors and BP will drive the stock momentum at least to the level it should achieve based on the financial potential of apabetalone and many of the other compounds within the 1500 in inventory.

Over the years I've been very critical of Don so I need to be fair and cautious. Don must be under tremendous pressure. He does not control the progress of the trial but what he should be managing is the perception of the brand. For years he has talked about licensing out the blood bank with no success. He gave GAC the impression at BB that Zenith would be sold in 2 to 3 months. Given Don's track record this type of statement does not give investors, or at least me, much confidence. We've all posted about the Medison Israel licensing deal (I do hope in the end it has merit). Let's hope there are licensing deals on the horizion but it appears based on current knowledge no one is banging at the door (as evidenced by the 3rd Eye financing).

Given all of the science that has been published and the pick up and positive findings by independent researchers it is impossible for me to understand the low valuation on this stock.

Mr Paradis did not work out for whatever reason. I don't recall that he did anything outstanding from a brand perspective. However, as has been pointed out he came from eneregy and not biotech. Sarah seems solid but she is not a brand builder and Don's flippant statements erode the brand.

I'd suggest as I did years ago that RVX requires brand building experts but few agreed. It may still make sense but now we are very close to the SSRA and then the science may have some positive momentum. However, without a strong brand and a highly credible management team in place with a solid track record the value of the stock may continue to not achieve it's potential in terms of value.

A really solid CVR would help, at least from my perspective.

Just some thoughts.

Toinv